Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124394432 | 12439443 | 2 | F | 2014 | 20160815 | 20160606 | 20160903 | PER | US-ASTRAZENECA-2016SE57010 | ASTRAZENECA | 78.00 | YR | F | Y | 55.30000 | KG | 20160903 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124394432 | 12439443 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | U | 21366 | 5 | MG | TABLET | QD | |||||
| 124394432 | 12439443 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | U | 21366 | 5 | MG | TABLET | QD | |||||
| 124394432 | 12439443 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | U | 21366 | TABLET | ||||||||
| 124394432 | 12439443 | 4 | C | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | AS REQUIRED | 0 | ||||||||||
| 124394432 | 12439443 | 5 | C | ALBUTEROL NEBULIZER | ALBUTEROL | 1 | Respiratory (inhalation) | DAILY | 0 | ||||||||||
| 124394432 | 12439443 | 6 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 0 | 1.5 | MG | QD | ||||||||
| 124394432 | 12439443 | 7 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 124394432 | 12439443 | 8 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124394432 | 12439443 | 1 | Blood cholesterol abnormal |
| 124394432 | 12439443 | 2 | Blood cholesterol abnormal |
| 124394432 | 12439443 | 3 | Blood cholesterol abnormal |
| 124394432 | 12439443 | 4 | Asthma |
| 124394432 | 12439443 | 5 | Asthma |
| 124394432 | 12439443 | 6 | Mental disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124394432 | 12439443 | Alopecia | |
| 124394432 | 12439443 | Blood cholesterol increased | |
| 124394432 | 12439443 | Body height decreased | |
| 124394432 | 12439443 | Memory impairment | |
| 124394432 | 12439443 | Pruritus | |
| 124394432 | 12439443 | Thyroid disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124394432 | 12439443 | 1 | 201604 | 0 | ||
| 124394432 | 12439443 | 2 | 201604 | 20160516 | 0 | |
| 124394432 | 12439443 | 4 | 198110 | 0 | ||
| 124394432 | 12439443 | 5 | 2007 | 0 |